Chapman, M. S.; Cirulli, J.; McBride, S. Sustained Improvement in Patient-Reported Outcomes With Continued Apremilast Treatment over 104 Weeks in Patients With Moderate to Severe Psoriasis. J of Skin 2018, 2, S23.